Table 1 Multiple published functional and association studies link genes identified by SWIF(r) to metabolism-related and obesity-related phenotypes
From: Localization of adaptive variants in human genomes using averaged one-dependence estimation
Gene | SNP(s) | DAF | P (sweep) | Studies relating gene to metabolism-obesity phenotype | Refs. |
---|---|---|---|---|---|
DNM3 | rs12121064 | 54% | 70% | Associated with waist–hip ratio in Europeans (rs1011731, GWA p = 7.5 × 10−9) | |
 |  |  |  | Associated with waist circumference in Hispanic women (GWA replication p = 1.5 × 10−3) | |
 |  |  |  | Associated with weight loss after gastric bypass surgery | |
ESRRG | rs11808388 | 62% | 99.2% | Regulates adipocyte differentiation by modulating the expression of adipogenesis-related genes | |
 |  |  |  | Candidate obesity-susceptibility gene based on epigenetic profile and association with BMI | |
 |  |  |  | May be involved in increasing the potential for energy expenditure in brown adipocytes | |
 |  |  |  | Mediates hepatic gluconeogenesis | |
 |  |  |  | Contributes toward maintenance of hepatic glucose homeostasis | |
 |  |  |  | Necessary for metabolic maturation of pancreatic β-cells | |
 |  |  |  | Significantly up-regulated under treatment with cholesterol drug fenofibrate | |
TTN | rs16866534 | 44% | 76% | Isoform composition in cardiac tissue is regulated by insulin signaling, possibly contributing to altered diastolic function in diabetic cardiomyopathy | |
MYH15 | rs3957559 | 49% | 76% | Variant rs3900940, along with four other variants, contributes to elevated risk for coronary heart disease | |
ADIPOQ | rs6444174 | 56% | 90% | rs6444174 associated with adiponectin levels in African-American women | |
 |  |  |  | Associated with plasma adiponectin levels in Europeans (rs17366568, GWA p = 4.3Ă—10−24) | |
 |  |  |  | Associated with plasma adiponectin levels in African Americans (rs4686807, GWA p = 1.6 × 10−11) | |
 |  |  |  | Associated with plasma adiponectin levels in East Asians (rs822391, GWA p = 1.6 × 10−10) | |
 |  |  |  | Associated with coronary heart disease, BMI, childhood obesity, metabolic syndrome, and type II diabetes | |
 |  |  |  | Serum adiponectin levels are associated with metabolic health and cardiovascular risk | |
PDGFRA | rs4530695 | 64% | 75% | Used in molecular biology as a marker for white adipocytes | |
 |  |  |  | Controls pancreatic β-cell proliferation | |
 |  |  |  | Plays a role in the link between obesity and inhibited placental development | |
ASTN2 | rs16934033 | 50% | 76% | Contributes to genetic variation of plasma triglyceride concentrations | |
 |  |  |  | marginally associated with childhood obesity in Hispanic individuals (GWA p = 2.4 × 10−6) | |
SIDT2 | rs11605217 | 27% | 57% | Important regulator of insulin secretion | |
 |  |  |  | Mice without the gene are glucose intolerant and have decreased serum insulin | |
 |  |  |  | Associated with triglyceride levels (rs1242229, GWA p = 3.1Ă—10−20) | |
RASSF8 | rs16929850 | 61% | 95.3% | Expression is significantly altered by fasting in mice | |
 | rs16929965 | 64% | 99.9% |  |  |
 | rs2729646 | 68% | 98.4% |  |  |
 | rs956627 | 64% | 99.9% |  |  |
DUT | rs11637235 | 33% | 76% | Missense variant causes a syndrome characterized in part by early onset diabetes mellitus | |
PEPD | rs12975240 | 62% | 76% | Associated with adiponectin levels in multiple populations (rs731839, rs4805885, rs8182584, rs889139, rs889140, GWA p values between 1.1 × 10−9 and 2.2 × 10−13) | |
 |  |  |  | Associated with type II diabetes (rs3786897, GWA p = 1.3 × 10−9) | |
 |  |  |  | Associated with fasting insulin levels (rs731839, GWA p = 5.1 × 10−12) | |
 |  |  |  | Associated with serum lipid levels | |
 |  |  |  | Expression is modulated by n-3 fatty acids | |
PHACTR3 | rs1182507 | 54% | 76% | Regulation in adipose tissue is BMI-dependent | |
 |  |  |  | Candidate obesity gene based on epigenetic profile |